# Relative Bioavailability and Food Effect Study of CVN424

> **NCT05635461** · PHASE1 · COMPLETED · sponsor: **Cerevance Beta, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** CVN424

## Key facts

- **NCT ID:** NCT05635461
- **Lead sponsor:** Cerevance Beta, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-09
- **Primary completion:** 2022-11-11
- **Final completion:** 2022-11-21
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635461, "Relative Bioavailability and Food Effect Study of CVN424". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05635461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*